Package 72162-1525-3

Brand: levocetirizine dihydrochloride

Generic: levocetirizine dihydrochloride
NDC Package

Package Facts

Identity

Package NDC 72162-1525-3
Digits Only 7216215253
Product NDC 72162-1525
Description

30 TABLET in 1 BOTTLE (72162-1525-3)

Marketing

Marketing Status
Marketed Since 2024-02-06
Brand levocetirizine dihydrochloride
Generic levocetirizine dihydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "aeb98202-0606-4fb8-8d1f-b8f13a95c568", "openfda": {"unii": ["SOD6A38AGA"], "rxcui": ["855172"], "spl_set_id": ["c79d3668-5243-4627-ad2b-cc7c045df120"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (72162-1525-3)", "package_ndc": "72162-1525-3", "marketing_start_date": "20240206"}], "brand_name": "levocetirizine dihydrochloride", "product_id": "72162-1525_aeb98202-0606-4fb8-8d1f-b8f13a95c568", "dosage_form": "TABLET", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "72162-1525", "generic_name": "levocetirizine dihydrochloride", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "levocetirizine dihydrochloride", "active_ingredients": [{"name": "LEVOCETIRIZINE DIHYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA203646", "marketing_category": "ANDA", "marketing_start_date": "20140909", "listing_expiration_date": "20261231"}